The independent source for health policy research, polling, and news.
2,201-2,220 of 3,723 results
A couple decided to donate a new test from their company to enable coronavirus testing for everyone in their ski resort community. It was an experiment that promised to show what widespread testing could do to fight the spread of COVID-19. But even the best-intended plans run into problems during this pandemic.
Frank Gabrin knew the stakes of his job. What he found unsettling was having to reuse personal protective gear while caring for coronavirus patients.
The spread of COVID-19 is prompting changes in pricing, coverage and other health care issues that have been subjects of political debate for years. But the politics remain polarized. Paige Winfield Cunningham of The Washington Post and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week that they think you should read, too.
California Gov. Gavin Newsom charged into 2020 with ambitious — and expensive — proposals to increase health insurance coverage, reduce homelessness and tackle drug prices. Then came COVID-19.
Public health researchers offered a range of ideas — from high-tech to tried-and-true public health interventions ― that could aid the U.S. response to COVID-19.
Reports offer a glimmer of hope, especially for older adults.
The Capital Senior Living chain of assisted living communities and others like it were struggling financially before coronavirus suddenly appeared. Now their situation is really getting tough.
The coronavirus death toll in Palm Beach County — home to President Donald Trump’s palatial home and club, Mar-a-Lago ― is the highest in Florida, where the large senior population is at risk.
Located about 45 minutes from New Orleans in one of the hardest-hit counties nationally, the 25-bed rural St. James Parish Hospital has hunkered down as staffers became infected, patient intake numbers have doubled, and intubations have skyrocketed. This is what it looks like inside a rural hospital when COVID-19 hits.
Government officials want to focus on fighting COVID-19 instead of recouping overcharges that run into the millions.
Foot traffic in L.A. has fallen off a cliff amid the COVID-19 crisis, driving many street vendors away. But some are still on the streets, peddling their wares out of economic necessity. Many are undocumented immigrants who won’t get any help from the recently approved $2 trillion federal assistance package.
The CDC recommends that Americans wear facial masks when they go to public places, such as the grocery store. But this is only one part of a multipronged effort to stop the virus’s spread.
The prospect raises a grim dilemma: Should doctors take people off life support in order to save COVID-19 patients who might recover?
As hospitals across the country are forced to delay or cancel certain medical procedures in response to the surge in patients with COVID-19, those hard choices are disrupting care for some people with serious illnesses.
Its older volunteers are staying home and its clients, mostly age 75 and up, are more vulnerable than ever.
Emergency rule changes by the federal government and some insurers have made telemedicine a useful tool.
Doctors are making decisions about a patient’s recovery with an incomplete understanding of the disease caused by the coronavirus. Although federal officials have issued general guidelines, physicians said they can’t offer recovered patients who aren’t retested any guarantees about whether they could transmit the virus.
KHN’s Julie Rovner examines what health care issues the administration might encounter if President Donald Trump wins in November.
Young adults are being hit hard in the COVID-19 economy, but many have mixed feelings about losing jobs that might otherwise put them in harm’s way in the midst of the pandemic.
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
© 2026 KFF